Conmed Corp. Stock

$50.95

2.80%

NYSE, Jul 25, 10:00 pm CET

ISIN

US2074101013

Symbol

CNMD

Reports

Quarter | Annual

Index

NYSE Composite, S&P SmallCap 600

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

Conmed Corp. Stock price

$50.95

-33.63 39.76% 5Y

NYSE, Closing price Fri, Jul 25 2025

+1.39 2.80%

ISIN

US2074101013

Symbol

CNMD

Reports

Quarter | Annual

Index

NYSE Composite, S&P SmallCap 600

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

$1.6b

Enterprise Value

$2.4b

Net debt

$856.7m

Cash

$35.5m

Shares outstanding

30.9m

Valuation (TTM | estimate)

P/E

13.3 | 11.4

P/S

1.2 | 1.1

EV/Sales

1.9 | 1.8

EV/FCF

14.8

P/B

1.6

Dividends

DPS

$0.80

Yield 1Y | 5Y

1.6% | 0.8%

Growth 1Y | 5Y

0.0% | 0.0%

Payout 1Y | 3Y

18.8% | 66.5%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$1.3b | $1.4b

EBITDA

$226.7m | $281.9m

EBIT

$191.9m | $212.7m

Net Income

$118.8m | $138.7m

Free Cash Flow

$164.6m

Growth (TTM | estimate)

Revenue

4.3% | 6.3%

EBITDA

23.0% | 15.6%

EBIT

28.5% | 1.7%

Net Income

44.3% | 4.7%

Free Cash Flow

16.3%

Financial Health

Equity Ratio

41.7%

Return on Equity

13.8%

ROCE

9.5%

ROIC

7.7%

Debt/Equity

0.9

EPS

$3.8

FCF per Share

$5.3

Short interest

9.3%

Employees

Rev per Employee

$340.0k

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Conmed Corp. Stock Analysis

Unlock Scores for Free

??

12 Analysts have issued a Conmed Corp. forecast:

6x Buy

50%

6x Hold

50%

More details on Analyst Estimates Including Price Targets

12 Analysts have issued a Conmed Corp. forecast:

Buy

50%

Hold

50%

Analyst Estimates with Stock Price Targets

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	1,316 1,316	4% 4% 100%
- Direct Costs	577 577	1% 1% 44%
Gross Profit	739 739	7% 7% 56%
- Selling and Administrative Expenses	469 469	2% 2% 36%
- Research and Development Expense	54 54	0% 0% 4%
EBITDA	227 227	23% 23% 17%
- Depreciation and Amortization	35 35	1% 1% 3%
EBIT (Operating Income) EBIT	192 192	28% 28% 15%
Net Profit	119 119	44% 44% 9%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Conmed Corp. Stock News

Neutral

Business Wire

●

20 days ago

Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Martha Aronson will be stepping down from the company's Board of Directors to assume the role of President and Chief Executive Officer at Merit Medical, a global leader in the development, manufacture and distribution of proprietary medical devices. Mrs. Aronson's resignation from the Board will be effective July...

Neutral

Business Wire

●

25 days ago

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2025 after the market close on Wednesday, July 30, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obt...

Neutral

Business Wire

●

2 months ago

CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne's extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will cont...

More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office	United States
CEO	Patrick Beyer
Employees	3,900
Founded	1970
Website	www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now